EP3571192
JAK1 valvísir hindrar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.1.2018EP published:
30.11.2022EP application number:
18701296.8
EP translation filed:
6.2.2023Grant published:
15.3.2023EPO information:
European Patent Register
Max expiry date:
15.1.2038Expiry date:
15.1.2027Next due date:
31.1.2027
Title in English:
JAK1 SELECTIVE INHIBITORSLanguage of the patent:
English
Timeline
Today
16.1.2018EP application
30.11.2022EP Publication
6.2.2023Translation submitted
15.3.2023Registration published
15.1.2027Expires
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
NILSSON, Karl, MagnusAddress:
431 83 Mölndal, SE
Name:
ÅSTRAND, Annika, Birgitta, MargaretaAddress:
431 83 Mölndal, SE
Name:
BERGGREN, Anna, Ingrid, KristinaAddress:
431 83 Mölndal, SE
Name:
JOHANSSON, Johan, R.Address:
431 83 Mölndal, SE
Name:
LEPISTÖ, Matti, JuhaniAddress:
431 83 Mölndal, SE
Name:
KAWATKAR, Sameer, PralhadAddress:
Wilmington, DE 19803, US
Name:
SU, QibinAddress:
Wilmington, DE 19803, US
Name:
KETTLE, Jason, GrantAddress:
Cambridge CB2 0AA, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762447057 PDate:
17.1.2017Country:
US
Classification
Categories:
C07D 403/04, C07D 403/14, A61K 31/506, A61P 17/14, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 25.1.2023
Expires: 15.1.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 18.12.2023
Expires: 15.1.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 27.12.2024
Expires: 15.1.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.1.2026
Expires: 15.1.2027
Payer: Árnason Faktor ehf.